ProQR Therap (PRQR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov7

ProQR Therapeutics released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 13.2 M, actual EPS USD -0.3712

04:00

ProQR Therapeutics released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 3.419 M (forecast USD 7.034 M), actual EPS USD -0.1225 (forecast USD -0.1197)

04:00

Nov5

Analyst Maintains Buy Rating on ProQR Stock

06:22

Oct15

Wolleben's Stock Recommendations Success Rate and Return Rate

13:12

Oct13

ProQR Therapeutics NV to Attend Chardan's 9th Annual Gene Therapy Conference

12:30

Oct1

ProQR Therapeutics stock price breaks above 50-day moving average

09:28

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 3.419 M, Net Income -12.91 M, EPS -0.1225

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.653 M, Net Income -14.26 M, EPS -0.1404

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 5.132 M, Net Income -10.91 M, EPS -0.1082

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More